Gilead and MicroDose Therapeutx announce license and collaboration agreement to develop MDT-637
20 April 2011 | By Gilead Sciences
Gilead & MicroDose Therapeutx have entered into an exclusive worldwide license...
List view / Grid view
20 April 2011 | By Gilead Sciences
Gilead & MicroDose Therapeutx have entered into an exclusive worldwide license...
22 February 2011 | By Gilead Sciences
Gilead Sciences, Inc. & Calistoga Pharmaceuticals, Inc., announced the signing of a definitive agreement pursuant to which Gilead will acquire Calistoga for $375 million...